NOW Foods
NOW NAC 600 mg
Budget product example for 600 mg NAC capsule — standard clinical dose for glutathione support.
Selection criteria
- • Budget pick for 600 mg NAC capsule — standard clinical dose for glutathione support.
Evidence Review · 6 References
N-acetylcysteine (NAC) can supply cysteine for glutathione synthesis, and glutathione is a major intracellular redox molecule. That biology is real. The mistake is turning it into one blanket consumer conclusion. Hospital antidote use, respiratory-disease trials, psychiatric studies, oral glutathione pharmacology, and vague “detox” claims are different evidence lanes.

Do not treat NAC as a general-purpose detox protocol. Its clearest medical use is prescription acetylcysteine for potentially hepatotoxic acetaminophen overdose under monitored care [1]. Respiratory evidence is mixed across meta-analyses [2,3], psychiatric trials are condition-specific [4], and oral glutathione can increase glutathione stores in humans rather than being categorically “destroyed in the gut” [5]. None of those findings proves that a healthy person should take NAC or glutathione every day for detox, anti-aging, liver cleansing, or hangover prevention.
At a Glance · Keep the Indications Separate
| Question | What is supported | Main limitation | What not to infer |
|---|---|---|---|
| Acetaminophen overdose | Prescription acetylcysteine is an antidote used to prevent or lessen hepatic injury after potentially hepatotoxic exposure [1]. | This is monitored toxicology care with specific treatment algorithms. | It does not establish a daily liver-protection supplement protocol. |
| COPD / chronic bronchitis | Some meta-analyses report fewer exacerbations and symptom/QoL signals [2]. | Other meta-analyses find no significant improvement in several COPD outcomes [3]. | Do not convert one pooled estimate into a universal dose or NNT. |
| Trichotillomania / psychiatric research | An adult randomized trial found a condition-specific signal for trichotillomania [4]. | Psychiatric evidence varies by diagnosis, trial, co-treatment, and population. | A positive adjunct trial is not a self-treatment recipe for OCD-spectrum conditions. |
| Oral glutathione | A six-month randomized trial found increases in glutathione stores in multiple compartments [5]. | Biomarker change does not automatically equal a clinically important outcome. | It is inaccurate to say oral glutathione is simply useless or completely destroyed. |
| General detox / wellness | Glutathione has important endogenous redox and detoxification roles [6]. | A physiologic pathway is not a validated supplement indication. | Do not inherit evidence from poisoning, COPD, or psychiatric trials. |
NAC can provide cysteine, a substrate relevant to glutathione synthesis [6]. That supports mechanism. It does not tell us whether supplementation improves a particular symptom, disease outcome, lifespan endpoint, or nonspecific feeling of “detox.” Each clinical claim needs its own human evidence.
Safety boundary
Suspected acetaminophen overdose is time-sensitive medical care, not a supplement experiment. Likewise, COPD, psychiatric symptoms, pregnancy, asthma, significant liver or kidney disease, and medication use can materially change the risk/benefit question. A product sold as NAC is not interchangeable with a hospital acetylcysteine protocol [1].
NAC and glutathione are biologically connected, but the evidence does not support one universal “NAC is better” or “glutathione is useless” rule. Use indication-specific evidence: prescription toxicology is one lane, respiratory trials another, psychiatric research another, and oral glutathione biomarker studies another. General detox and wellness claims require evidence of their own.
No. NAC has important indication-specific uses, including prescription use for acetaminophen poisoning and research in respiratory and psychiatric conditions. Those data do not establish a routine daily NAC protocol for general detox, liver cleansing, hangovers, or wellness.
That claim is too categorical. A six-month randomized trial found oral glutathione increased glutathione stores in several tissues and blood compartments. Formulation can affect pharmacokinetics, but higher glutathione levels do not automatically prove a clinical benefit for a disease or wellness goal.
The evidence is mixed. A 2024 meta-analysis reported fewer exacerbations in COPD and chronic bronchitis/pre-COPD, while another modern meta-analysis found no significant benefit across several COPD outcomes. The result depends on population, regimen, background treatment, and study selection.
NAC has been studied as an adjunct in psychiatric research, but results are condition-specific and should not be converted into a self-treatment protocol. The adult trichotillomania randomized trial is Grant et al. 2009 (PMID 19581567).
No. Intravenous acetylcysteine is a prescription antidote used with laboratory monitoring and poison-control or hospital protocols after potentially hepatotoxic acetaminophen exposure. That indication does not imply that routine oral NAC supplementation prevents liver injury in healthy people.
Source ledger
6 sources
Sourcing options
Product links are sourcing examples, not a treatment, detox, or dosing recommendation. Match any use to the specific evidence and your medication/health context.
Affiliate disclosure: we may earn a commission from qualifying links at no extra cost to you. How we stay independent.
Free safety checklist
NAC, glutathione, antioxidants — evidence by indication, not marketing shortcuts.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Editorial reading context
Evidence review of NAC and glutathione separating acetaminophen poisoning, respiratory disease, psychiatric research, oral glutathione pharmacology, and… This guide is intended to help readers make sense of evidence, safety, and practical fit without turning supplement research into a one-size-fits-all checklist. Use it alongside the linked herb and compound profiles for deeper mechanism and safety details.
For NAC & Glutathione: One Biochemical System, Several Different Clinical Questions, focus on whether the evidence matches the exact outcome you care about, whether the dose discussed is realistic, and whether the safety profile fits your medical context. Strong marketing language should carry less weight than human evidence and transparent product quality.
When a page discusses dependence-forming substances, restricted compounds, or high-risk contexts, treat it as harm-reduction education only. It is not a buying guide, dosing instruction, or substitute for professional care.